The CDK inhibitor p18Ink4c is a tumor suppressor in medulloblastoma

Tamar Uziel1, Frederique Zindy, Charles J Sherr

  • 1Department of Genetics & Tumor Cell Biology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA.

Insights

The cyclin-dependent kinase inhibitor p18(Ink4c) plays a crucial role in preventing pediatric medulloblastoma (MB). Loss of p18(Ink4c) function collaborates with other genetic changes to drive MB formation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Medulloblastoma (MB) is the most common pediatric brain malignancy.
  • MB is believed to arise from cerebellar granule cell precursors (CGNPs) that fail to differentiate.
  • While Sonic Hedgehog (Shh) pathway mutations are found in 30% of MBs, other genetic drivers remain largely unknown.

Purpose of the Study:

  • To investigate the role of p18(Ink4c), a cyclin-dependent kinase inhibitor, in medulloblastoma development.
  • To explore the collaborative effects of Ink4c loss with other genetic alterations (p53, Ptc1) in MB formation.

Main Methods:

  • Analysis of Ink4c function in mouse models of medulloblastoma.
  • Investigating the genetic cooperation between Ink4c, p53, and the Shh pathway receptor Ptc1.
  • Examining INK4C promoter methylation and p18(INK4C) protein expression in human MB samples.

Main Results:

  • Disruption of Ink4c collaborates with p53 loss or Ptc1 inactivation to induce MB in mice.
  • Ink4c loss is required for MB formation in p53-null mice and is haplo-insufficient in a Ptc(1+/-) background.
  • Human MBs frequently show INK4C promoter methylation and loss of p18(INK4C) protein, indicating its tumor-suppressive role.

Conclusions:

  • p18(Ink4c) functions as a critical tumor suppressor in medulloblastoma.
  • Loss of Ink4c function is a significant factor in MB pathogenesis, particularly in conjunction with other genetic alterations.
  • INK4C represents a potential therapeutic target for medulloblastoma.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...